VMA21

Vacuolar ATPase assembly integral membrane protein VMA21 · Q3ZAQ7 · VMA21 on Sugi Atlas →

0 patent compounds predicted against VMA21, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to VMA21 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
The Possible Efficacy and Safety of Lansoprazole Co-administration With Neoadjuvant Chemotherapy in Women With Breast Cancer PHASE3COMPLETED
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant PHASE1/PHASE2RECRUITING
Nilotinib in Huntington's Disease PHASE1UNKNOWN
Pilot Study of Protein Profiling of the Human Epidermal Cells After Ultraviolet Irradiation EARLY_PHASE1COMPLETED
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer nanUNKNOWN
Stem Cell Models of Best Disease and Other Retinal Degenerative Diseases. nanCOMPLETED
Vacuolar ATPase and Drug Resistance of High Grade Gliomas nanUNKNOWN
Open-Label Study of Omega 3 Oil Supplementation for Aging-Related Cognitive Decline nanCOMPLETED
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts nanCOMPLETED
Genetic Analysis of Hereditary Disorders of Hearing and Balance nanCOMPLETED
Natural History Study of Mitochondrial Myopathy nanRECRUITING
Multidisciplinary Study of Right Ventricular Dysplasia nanCOMPLETED
PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Changes in the Hepatobiliary System in Patients With Primary Biliary Cholangitis Before and After Treatment. nanACTIVE_NOT_RECRUITING
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis) nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease nanRECRUITING
Study of Constitutional Platelet Disease nanUNKNOWN
Genetic Analysis of Gray Platelet Syndrome nanCOMPLETED
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Mechanisms of Inherited Retinal Dystrophies Using Whole Genome Sequencing and in Vitro and in Vivo Models nanCOMPLETED
Cell Free Circulating Nucleic Acids as New Tumor Diagnostics From Human Plasma Samples. nanUNKNOWN
PREcision Diagnostics in Rare genetIC Diseases and Tumors - Long Read Sequencing nanRECRUITING
Protein Synthesis in the Brain of Patients With Fragile X Syndrome nanCOMPLETED
Study of Chediak-Higashi Syndrome nanRECRUITING
Biomarkers in Retinitis Pigmentosa nanUNKNOWN
Mitoquines in COPD nanUNKNOWN
The Role of Arachidonic Acid Metabolites, From Patients With Metabolic Syndrome nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a VMA21 binder may also engage these)

ProteinNameSimilarity
Q5RDV3 1.000 Q5RDV3 →
A2VDK9 1.000 A2VDK9 →
Q78T54 1.000 Q78T54 →
Q5ZLL0 0.991 Q5ZLL0 →
Q28GR4 0.985 Q28GR4 →
Q4V7U1 0.982 Q4V7U1 →
B8JLV7 0.969 B8JLV7 →
Q3SYY9 0.964 Q3SYY9 →
Q6UWH6 0.962 Q6UWH6 →
Q62302 0.961 Q62302 →
Q58DA4 0.960 Q58DA4 →
Q4R5E3 0.959 Q4R5E3 →
A9JRA0 0.959 A9JRA0 →
Q4R512 0.959 Q4R512 →
Q5M8Y1 0.958 Q5M8Y1 →
Q8K0B2 0.958 Q8K0B2 →
Q5RFE0 0.958 Q5RFE0 →
Q5BJW3 0.958 Q5BJW3 →
Q0VCK9 0.958 Q0VCK9 →
Q9NUN5 0.957 Q9NUN5 →
Q9CYN2 0.956 Q9CYN2 →
B0FWK4 0.956 B0FWK4 →
Q8CIF6 0.956 Q8CIF6 →
Q99KU0 0.956 Q99KU0 →
Q5F409 0.955 Q5F409 →
D3ZEH5 0.955 D3ZEH5 →
Q5RAY6 0.955 Q5RAY6 →
Q7ZUA6 0.955 Q7ZUA6 →
Q6AZ61 0.954 Q6AZ61 →
Q6NYF1 0.954 Q6NYF1 →